Related Experiment Video
Updated: Aug 20, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
Update: influenza activity--United States, 2004-05 season
Abstract:
Influenza activity was low in the United States during October through early December but has increased steadily since mid-December. Current surveillance indicators suggest that influenza activity for the season has not yet peaked. Laboratory-confirmed influenza infections have been reported from 45 states, and this season's influenza vaccine strains have been well matched antigenically to the influenza viruses isolated so far this season. In response to this season's influenza vaccine supply shortage, the Department of Health and Human Services (DHHS) has purchased 1.2 million doses of 2004-05 inactivated influenza vaccine from GlaxoSmithKline (GSK). The GSK vaccine is produced, licensed, and distributed globally but is not licensed for use in the United States; therefore, it will be administered in the United States under an Investigational New Drug (IND) protocol. This report summarizes influenza activity during October 3, 2004-January 1, 2005 and provides information on the availability of additional influenza vaccine from GSK.
Insights
Influenza activity increased in the US starting mid-December, with 45 states reporting infections. An Investigational New Drug protocol will allow the use of additional imported influenza vaccine due to supply shortages.
Area of Science:
- Public Health
- Epidemiology
- Virology
Background:
- Influenza activity in the United States was low from October to early December 2004.
- Activity began to increase steadily in mid-December, indicating the season had not yet peaked.
- Laboratory-confirmed influenza infections were reported across 45 states.
Purpose of the Study:
- To summarize influenza activity in the US from October 3, 2004, to January 1, 2005.
- To provide information on the availability of additional influenza vaccine.
- To address the influenza vaccine supply shortage.
Main Methods:
- Surveillance data analysis for influenza activity.
- Antigenic characterization of circulating influenza viruses.
- Description of the procurement and administration of imported influenza vaccine.
Main Results:
- Influenza activity increased significantly after mid-December 2004.
- Circulating influenza viruses were antigenically well-matched to the 2004-05 vaccine strains.
- 1.2 million doses of inactivated influenza vaccine were purchased from GlaxoSmithKline (GSK) to supplement the domestic supply.
Conclusions:
- The 2004-05 influenza season activity increased after mid-December.
- A vaccine supply shortage necessitated the use of imported GSK vaccine under an Investigational New Drug (IND) protocol.
- The antigenic match between vaccine strains and circulating viruses was favorable.
Related Concept Videos
Influenza
Vaccinations
Inhibitors Of Virion Release
Infectious Diseases and Their Occurrence
Smallpox

